F3Logic LLC decreased its holdings in Clorox Co (NYSE:CLX) by 19.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,460 shares of the company’s stock after selling 2,946 shares during the quarter. F3Logic LLC’s holdings in Clorox were worth $1,985,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Athena Capital Advisors LLC purchased a new position in Clorox during the 4th quarter worth $25,000. Meeder Asset Management Inc. purchased a new position in Clorox during the 4th quarter worth $26,000. Capital Financial Planning LLC purchased a new position in Clorox during the 4th quarter worth $32,000. Paragon Capital Management LLC purchased a new position in Clorox during the 1st quarter worth $35,000. Finally, City Holding Co. raised its position in Clorox by 150.0% during the 4th quarter. City Holding Co. now owns 250 shares of the company’s stock worth $39,000 after buying an additional 150 shares during the last quarter. Hedge funds and other institutional investors own 77.91% of the company’s stock.
A number of equities analysts have commented on the stock. BMO Capital Markets set a $168.00 price objective on shares of Clorox and gave the stock a “buy” rating in a research report on Thursday, May 2nd. Wells Fargo & Co lowered their price target on shares of Clorox from $157.00 to $153.00 and set a “market perform” rating on the stock in a research note on Thursday, May 2nd. Bank of America reaffirmed a “neutral” rating and set a $154.00 price target (down from $165.00) on shares of Clorox in a research note on Thursday, May 2nd. Citigroup lowered their price target on shares of Clorox from $171.00 to $160.00 and set a “neutral” rating on the stock in a research note on Thursday, May 2nd. Finally, Deutsche Bank raised shares of Clorox from a “sell” rating to a “hold” rating and set a $139.00 price target on the stock in a research note on Thursday, May 2nd. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $149.57.
In related news, SVP Andrew J. Mowery sold 5,340 shares of the stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $156.44, for a total value of $835,389.60. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.40% of the stock is currently owned by corporate insiders.
Shares of NYSE:CLX traded up $0.60 on Wednesday, reaching $147.83. 4,543 shares of the company were exchanged, compared to its average volume of 1,229,580. The stock has a market cap of $19.00 billion, a PE ratio of 23.63, a price-to-earnings-growth ratio of 4.34 and a beta of 0.31. Clorox Co has a 1-year low of $115.74 and a 1-year high of $167.70. The company has a quick ratio of 0.66, a current ratio of 1.10 and a debt-to-equity ratio of 2.93.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, May 1st. The company reported $1.44 EPS for the quarter, missing the Zacks’ consensus estimate of $1.47 by ($0.03). The business had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.57 billion. Clorox had a net margin of 12.68% and a return on equity of 108.82%. Clorox’s revenue was up 2.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.37 earnings per share. Equities analysts anticipate that Clorox Co will post 6.29 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 10th. Investors of record on Wednesday, April 24th were paid a $0.96 dividend. The ex-dividend date of this dividend was Tuesday, April 23rd. This represents a $3.84 dividend on an annualized basis and a yield of 2.60%. Clorox’s payout ratio is 61.34%.
TRADEMARK VIOLATION NOTICE: This news story was first reported by Highlight Press and is the property of of Highlight Press. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://highlightpress.com/2019/05/15/f3logic-llc-trims-position-in-clorox-co-clx.html.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
See Also: What are gap-up stocks?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.